id	sid	eid	entity	type
admet-352	1	1	10.5599	CARDINAL
admet-352	1	2	1	CARDINAL
admet-352	1	3	5(1	CARDINAL
admet-352	1	4	2017	CARDINAL
admet-352	1	5	1	CARDINAL
admet-352	1	6	10.5599	CARDINAL
admet-352	1	7	issn	PERSON
admet-352	1	8	1848-7718	DATE
admet-352	1	9	alk	ORG
admet-352	1	10	fernando franco	PERSON
admet-352	1	11	míriam méndez*	PERSON
admet-352	1	12	lourdes gutierrez	GPE
admet-352	1	13	mariano provencio puerta de hierro universitary hospital	ORG
admet-352	1	14	madrid	GPE
admet-352	1	15	spain	GPE
admet-352	2	1	october 25,	DATE
admet-352	2	2	2016	DATE
admet-352	2	3	february 22, 2017	DATE
admet-352	2	4	march 25	DATE
admet-352	2	5	2017	DATE
admet-352	3	1	85 %	PERCENT
admet-352	5	1	the united states	GPE
admet-352	5	2	approximately 130,000	CARDINAL
admet-352	5	3	a year	DATE
admet-352	9	1	85 %	PERCENT
admet-352	11	1	the united states	GPE
admet-352	11	2	approximately 130,000	CARDINAL
admet-352	11	3	per year	DATE
admet-352	11	4	1	CARDINAL
admet-352	14	1	alk	ORG
admet-352	14	2	2	CARDINAL
admet-352	15	1	approximately 15 percent	PERCENT
admet-352	15	2	the united states	GPE
admet-352	15	3	5	CARDINAL
admet-352	16	1	asian	NORP
admet-352	16	2	up to 62 percent	PERCENT
admet-352	16	3	6	CARDINAL
admet-352	18	1	about 4 percent	PERCENT
admet-352	20	1	asian	NORP
admet-352	21	1	http://www.pub.iapchem.org/ojs/index.php/admet/index m. mendez et al	PERSON
admet-352	21	2	5(1	CARDINAL
admet-352	21	3	2017	CARDINAL
admet-352	21	4	1	CARDINAL
admet-352	21	5	first	ORDINAL
admet-352	21	6	second	ORDINAL
admet-352	22	1	5,7	CARDINAL
admet-352	23	1	first	ORDINAL
admet-352	24	1	5-13 months	DATE
admet-352	25	1	second	ORDINAL
admet-352	25	2	first	ORDINAL
admet-352	25	3	egfr	PRODUCT
admet-352	25	4	her4	GPE
admet-352	25	5	19	CARDINAL
admet-352	27	1	9-11	CARDINAL
admet-352	28	1	third	ORDINAL
admet-352	28	2	over 60 %	PERCENT
admet-352	28	3	first	ORDINAL
admet-352	28	4	second	ORDINAL
admet-352	30	1	790	CARDINAL
admet-352	30	2	2	CARDINAL
admet-352	30	3	1	CARDINAL
admet-352	30	4	mapk1	ORG
admet-352	31	1	12-15	CARDINAL
admet-352	32	1	less than two years	DATE
admet-352	32	2	m. osimertinib	PERSON
admet-352	32	3	fda	ORG
admet-352	32	4	november 2015	DATE
admet-352	32	5	third	ORDINAL
admet-352	33	1	two	CARDINAL
admet-352	33	2	az5104	PERSON
admet-352	34	1	az5104	PERSON
admet-352	34	2	19	CARDINAL
admet-352	35	1	first	ORDINAL
admet-352	35	2	11	CARDINAL
admet-352	35	3	16	CARDINAL
admet-352	36	1	between 20 and 240 mg	CARDINAL
admet-352	37	1	67 %	PERCENT
admet-352	37	2	95 %	PERCENT
admet-352	37	3	52-70 %	PERCENT
admet-352	37	4	21 %	PERCENT
admet-352	38	1	91 %	PERCENT
admet-352	39	1	9.6 months	DATE
admet-352	39	2	3 months	DATE
admet-352	40	1	1	CARDINAL
admet-352	40	2	2	CARDINAL
admet-352	42	1	80	CARDINAL
admet-352	42	2	16	CARDINAL
admet-352	43	1	40 mg	QUANTITY
admet-352	43	2	40	CARDINAL
admet-352	44	1	16	CARDINAL
admet-352	47	1	5(1	CARDINAL
admet-352	47	2	2017	CARDINAL
admet-352	47	3	1	CARDINAL
admet-352	47	4	10.5599	CARDINAL
admet-352	47	5	3	CARDINAL
admet-352	47	6	19	DATE
admet-352	48	1	19-20	CARDINAL
admet-352	51	1	asco 2015	LAW
admet-352	51	2	59 %	PERCENT
admet-352	51	3	95 %	PERCENT
admet-352	51	4	45-73	CARDINAL
admet-352	51	5	85 %	PERCENT
admet-352	52	1	only around 30 %	PERCENT
admet-352	53	1	1	CARDINAL
admet-352	53	2	21	CARDINAL
admet-352	54	1	10 %	PERCENT
admet-352	55	1	51 %	PERCENT
admet-352	55	2	22 %	PERCENT
admet-352	55	3	11 %	PERCENT
admet-352	56	1	fifty-seven percent	PERCENT
admet-352	56	2	22 %	PERCENT
admet-352	56	3	10 %	PERCENT
admet-352	56	4	10 %	PERCENT
admet-352	57	1	8 months	DATE
admet-352	57	2	500-650 mg	QUANTITY
admet-352	58	1	fda	ORG
admet-352	58	2	21	CARDINAL
admet-352	59	1	1482694	DATE
admet-352	59	2	egfr	PRODUCT
admet-352	60	1	l858r	PERSON
admet-352	61	1	i / ii	EVENT
admet-352	61	2	800 mg	QUANTITY
admet-352	62	1	62 %	PERCENT
admet-352	63	1	91 %	PERCENT
admet-352	64	1	55 %	PERCENT
admet-352	64	2	37 %	PERCENT
admet-352	64	3	38 %	PERCENT
admet-352	64	4	36 %	PERCENT
admet-352	64	5	23	CARDINAL
admet-352	66	1	1	CARDINAL
admet-352	66	2	1482694	DATE
admet-352	66	3	first	ORDINAL
admet-352	67	1	asp8273 asp8273	ORG
admet-352	67	2	t790m.	PERSON
admet-352	67	3	xenograft models	ORG
admet-352	67	4	asp8273	ORG
admet-352	67	5	14 days	DATE
admet-352	68	1	400	CARDINAL
admet-352	70	1	400-600	CARDINAL
admet-352	71	1	300 mg	QUANTITY
admet-352	72	1	25 %	PERCENT
admet-352	72	2	24	CARDINAL
admet-352	74	1	26	CARDINAL
admet-352	75	1	third	ORDINAL
admet-352	75	2	mek	ORG
admet-352	76	1	m. mendez et al	PERSON
admet-352	76	2	5(1	CARDINAL
admet-352	76	3	2017	CARDINAL
admet-352	76	4	1	CARDINAL
admet-352	77	1	4	CARDINAL
admet-352	77	2	2	CARDINAL
admet-352	77	3	alk	PERSON
admet-352	78	1	alk	ORG
admet-352	79	1	3–7 %	PERCENT
admet-352	79	2	kras	PERSON
admet-352	80	1	31	CARDINAL
admet-352	81	1	ihc	ORG
admet-352	83	1	at least 15 %	PERCENT
admet-352	83	2	50	CARDINAL
admet-352	84	1	ihc	ORG
admet-352	86	1	2015	DATE
admet-352	86	2	ihc	ORG
admet-352	86	3	94 %	PERCENT
admet-352	86	4	32	CARDINAL
admet-352	87	1	first	ORDINAL
admet-352	87	2	pf-02341066	GPE
admet-352	87	3	xalkori	GPE
admet-352	88	1	crizotinib	PERSON
admet-352	88	2	first	ORDINAL
admet-352	88	3	4	CARDINAL
admet-352	90	1	first	ORDINAL
admet-352	90	2	33	CARDINAL
admet-352	91	1	approximately 60 %	PERCENT
admet-352	91	2	40 %	PERCENT
admet-352	92	1	one	CARDINAL
admet-352	92	2	35	CARDINAL
admet-352	94	1	30 %	PERCENT
admet-352	94	2	36	CARDINAL
admet-352	94	3	kras	PERSON
admet-352	94	4	37	CARDINAL
admet-352	94	5	about 50 %	PERCENT
admet-352	95	1	38	CARDINAL
admet-352	95	2	40	CARDINAL
admet-352	96	1	second	ORDINAL
admet-352	96	2	1	CARDINAL
admet-352	97	1	ceritinib ceritinib	PERSON
admet-352	97	2	20-fold	CARDINAL
admet-352	97	3	41	CARDINAL
admet-352	98	1	s1206y	NORP
admet-352	99	1	f1174c crizotinib	PERSON
admet-352	100	1	daily	DATE
admet-352	100	2	750 mg	QUANTITY
admet-352	101	1	246	CARDINAL
admet-352	101	2	163	CARDINAL
admet-352	101	3	83	CARDINAL
admet-352	102	1	56.4 %	PERCENT
admet-352	102	2	72.3 %	PERCENT
admet-352	102	3	61.8 %	PERCENT
admet-352	102	4	18.4	CARDINAL
admet-352	102	5	9.0	CARDINAL
admet-352	102	6	6.9 months	DATE
admet-352	103	1	124	CARDINAL
admet-352	103	2	28	CARDINAL
admet-352	103	3	8	CARDINAL
admet-352	103	4	admet &	ORG
admet-352	103	5	5(1	CARDINAL
admet-352	103	6	2017	CARDINAL
admet-352	103	7	1	CARDINAL
admet-352	103	8	10.5599	CARDINAL
admet-352	103	9	5	CARDINAL
admet-352	104	1	36 %	PERCENT
admet-352	104	2	95 %	PERCENT
admet-352	104	3	63 %	PERCENT
admet-352	104	4	95 %	PERCENT
admet-352	104	5	25–92 %	PERCENT
admet-352	104	6	33,34	CARDINAL
admet-352	105	1	124	CARDINAL
admet-352	105	2	40.3 %	PERCENT
admet-352	105	3	46 %	PERCENT
admet-352	106	1	63.7 %	PERCENT
admet-352	106	2	95 %	PERCENT
admet-352	107	1	20 %	PERCENT
admet-352	107	2	95 %	PERCENT
admet-352	107	3	2.5	CARDINAL
admet-352	107	4	55.6 %	PERCENT
admet-352	108	1	35	CARDINAL
admet-352	109	1	two	CARDINAL
admet-352	109	2	first	ORDINAL
admet-352	109	3	second	ORDINAL
admet-352	110	1	alectinib alectinib	PERSON
admet-352	110	2	ret	ORG
admet-352	111	1	japan	GPE
admet-352	111	2	first	ORDINAL
admet-352	112	1	46	CARDINAL
admet-352	112	2	43	CARDINAL
admet-352	112	3	93.5 %	PERCENT
admet-352	112	4	95 %	PERCENT
admet-352	112	5	82.1–98.6	CARDINAL
admet-352	113	1	2-year	DATE
admet-352	113	2	76 %	PERCENT
admet-352	113	3	95 %	PERCENT
admet-352	113	4	60–86 %	PERCENT
admet-352	113	5	2-year	DATE
admet-352	113	6	79 %	PERCENT
admet-352	113	7	95 %	PERCENT
admet-352	113	8	63–89 %	PERCENT
admet-352	114	1	47	CARDINAL
admet-352	115	1	55 %	PERCENT
admet-352	115	2	21	CARDINAL
admet-352	115	3	90 %	PERCENT
admet-352	116	1	600 mg	QUANTITY
admet-352	116	2	44	CARDINAL
admet-352	117	1	47	CARDINAL
admet-352	118	1	71 %	PERCENT
admet-352	118	2	100 %	PERCENT
admet-352	119	1	13.4 months	DATE
admet-352	119	2	50	CARDINAL
admet-352	120	1	2	CARDINAL
admet-352	121	1	alk	PERSON
admet-352	122	1	ntrk1	DATE
admet-352	122	2	approximately 3 %	PERCENT
admet-352	122	3	51	CARDINAL
admet-352	123	1	52	CARDINAL
admet-352	124	1	400 mg/m2	QUANTITY
admet-352	125	1	53	CARDINAL
admet-352	126	1	third	ORDINAL
admet-352	126	2	lorlatinib	PERSON
admet-352	126	3	1198	CARDINAL
admet-352	126	4	only approximately 25 %	PERCENT
admet-352	126	5	alk	ORG
admet-352	126	6	1	CARDINAL
admet-352	127	1	54	CARDINAL
admet-352	128	1	lorlatinib	PERSON
admet-352	128	2	alk g1202r	PERSON
admet-352	129	1	m. mendez et al	PERSON
admet-352	129	2	5(1	CARDINAL
admet-352	129	3	2017	CARDINAL
admet-352	129	4	1-8 6	TIME
admet-352	130	1	55	CARDINAL
admet-352	133	1	two	CARDINAL
admet-352	133	2	56	CARDINAL
admet-352	134	1	cep-28122	TIME
admet-352	134	2	alk	ORG
admet-352	135	1	cep37440	ORG
admet-352	136	1	57	CARDINAL
admet-352	137	1	60-62	CARDINAL
admet-352	139	1	crizotinib	PERSON
admet-352	140	1	auy922	PRODUCT
admet-352	140	2	1	CARDINAL
admet-352	140	3	second	ORDINAL
admet-352	140	4	third	ORDINAL
admet-352	142	1	alectinib ltk	PERSON
admet-352	142	2	gak sens	PERSON
admet-352	142	3	trkc	GPE
admet-352	142	4	nd lorlatinib ros1	PERSON
admet-352	142	5	trkc sens	ORG
admet-352	146	1	5(1	CARDINAL
admet-352	146	2	2017	CARDINAL
admet-352	146	3	1	CARDINAL
admet-352	146	4	10.5599	CARDINAL
admet-352	146	5	7	CARDINAL
admet-352	146	6	1	CARDINAL
admet-352	146	7	r. siegel	PERSON
admet-352	146	8	j. ma	PERSON
admet-352	146	9	z. zou	PERSON
admet-352	146	10	a. jemal	PERSON
admet-352	147	1	j. clin	PERSON
admet-352	148	1	64(1	TIME
admet-352	148	2	2014	DATE
admet-352	148	3	9	CARDINAL
admet-352	149	1	2	CARDINAL
admet-352	149	2	p. cagle	PERSON
admet-352	149	3	m.b. beasley et al	PERSON
admet-352	152	1	137(6	TIME
admet-352	152	2	2013	DATE
admet-352	152	3	828–860	CARDINAL
admet-352	153	1	3	CARDINAL
admet-352	153	2	lynch	GPE
admet-352	153	3	d.w. bell	ORG
admet-352	153	4	r. sordella	PERSON
admet-352	154	1	j. med.	ORG
admet-352	155	1	2004	DATE
admet-352	156	1	4	CARDINAL
admet-352	156	2	kwak	GPE
admet-352	156	3	y.j	GPE
admet-352	156	4	bang	GPE
admet-352	156	5	d.r.	GPE
admet-352	157	1	j. med	PERSON
admet-352	158	1	363(18	CARDINAL
admet-352	158	2	2010	DATE
admet-352	158	3	1693-1703	DATE
admet-352	159	1	5	CARDINAL
admet-352	159	2	r. rosell	PERSON
admet-352	159	3	e. carcereny	PERSON
admet-352	159	4	r. gervais	PERSON
admet-352	161	1	13(3	CARDINAL
admet-352	161	2	2012	DATE
admet-352	162	1	239–246	CARDINAL
admet-352	163	1	6] f.-y	CARDINAL
admet-352	164	1	niu	ORG
admet-352	164	2	y.-l.wu	GPE
admet-352	166	1	3(1	CARDINAL
admet-352	166	2	2014	DATE
admet-352	167	1	2	CARDINAL
admet-352	168	1	7	CARDINAL
admet-352	168	2	n. rekhtman	PERSON
admet-352	168	3	w.a.	GPE
admet-352	169	1	j. clin	PERSON
admet-352	171	1	2014) 3673	DATE
admet-352	172	1	8	CARDINAL
admet-352	172	2	a. chi	PERSON
admet-352	172	3	s. remick	PERSON
admet-352	172	4	w. tse	PERSON
admet-352	172	5	biomark	PERSON
admet-352	173	1	1(1	CARDINAL
admet-352	173	2	2013	DATE
admet-352	173	3	2	CARDINAL
admet-352	174	1	9	CARDINAL
admet-352	174	2	lee	PERSON
admet-352	175	1	wu	PERSON
admet-352	175	2	p.n.	GPE
admet-352	176	1	j. clin	PERSON
admet-352	177	1	oncol	TIME
admet-352	178	1	2015	CARDINAL
admet-352	178	2	1958–1965	CARDINAL
admet-352	179	1	10	CARDINAL
admet-352	179	2	r.t.	PERSON
admet-352	179	3	sjin	PERSON
admet-352	179	4	haringsma	PERSON
admet-352	180	1	3(12	CARDINAL
admet-352	180	2	2013	DATE
admet-352	180	3	1404–1415	DATE
admet-352	181	1	11	CARDINAL
admet-352	181	2	s.e. ashton	GPE
admet-352	181	3	s. ghiorghiu	PERSON
admet-352	182	1	4(9	CARDINAL
admet-352	183	1	2014	DATE
admet-352	183	2	1046–1061	CARDINAL
admet-352	184	1	12	CARDINAL
admet-352	184	2	s. kobayashi	PERSON
admet-352	184	3	t.j. boggon	PERSON
admet-352	184	4	t. dayaram	PERSON
admet-352	185	1	j. med	PERSON
admet-352	186	1	352	CARDINAL
admet-352	186	2	2005	DATE
admet-352	187	1	786–792	CARDINAL
admet-352	188	1	13	CARDINAL
admet-352	188	2	j.a. engelman	ORG
admet-352	188	3	k. zejnullahu	PERSON
admet-352	188	4	t. mitsudomi	GPE
admet-352	188	5	316	DATE
admet-352	188	6	2007	DATE
admet-352	188	7	1039–1043	CARDINAL
admet-352	189	1	14	CARDINAL
admet-352	189	2	k. takezawa	PERSON
admet-352	189	3	v. pirazzoli	PERSON
admet-352	189	4	m.e.	GPE
admet-352	190	1	2	CARDINAL
admet-352	190	2	2012	DATE
admet-352	191	1	922–933	CARDINAL
admet-352	192	1	15	CARDINAL
admet-352	192	2	kim	PERSON
admet-352	192	3	a. song	PERSON
admet-352	193	1	kim	PERSON
admet-352	194	1	j. thorac	PERSON
admet-352	195	1	oncol.	DATE
admet-352	196	1	10 (	PERCENT
admet-352	197	1	16	CARDINAL
admet-352	197	2	p.a. jänne	GPE
admet-352	197	3	j.c. yang	PERSON
admet-352	197	4	d.w.	PERSON
admet-352	198	1	kim	PERSON
admet-352	199	1	j. med.	PERSON
admet-352	200	1	2015	CARDINAL
admet-352	200	2	1689	CARDINAL
admet-352	201	1	17	CARDINAL
admet-352	201	2	j. yang	PERSON
admet-352	201	3	c. lee	PERSON
admet-352	201	4	j. thoracic	PERSON
admet-352	202	1	oncol.	DATE
admet-352	203	1	2015	DATE
admet-352	205	1	18	CARDINAL
admet-352	205	2	c.a. eberlein	PERSON
admet-352	205	3	d. stetson	PERSON
admet-352	205	4	a.a.	GPE
admet-352	206	1	2015	CARDINAL
admet-352	206	2	2489–500	CARDINAL
admet-352	207	1	19	CARDINAL
admet-352	207	2	r.t.	PERSON
admet-352	207	3	sjin	PERSON
admet-352	207	4	haringsma	PERSON
admet-352	208	1	3 (2013	DATE
admet-352	208	2	1404-1415	DATE
admet-352	209	1	20	CARDINAL
admet-352	209	2	j.c. soria	PERSON
admet-352	209	3	j.w.	GPE
admet-352	209	4	goldman	ORG
admet-352	210	1	j. med.	PERSON
admet-352	211	1	2015	CARDINAL
admet-352	211	2	1700–1709	CARDINAL
admet-352	212	1	21	CARDINAL
admet-352	212	2	soria	GPE
admet-352	212	3	d.r.	GPE
admet-352	214	1	j. med	PERSON
admet-352	215	1	374	CARDINAL
admet-352	215	2	2016	CARDINAL
admet-352	215	3	22	CARDINAL
admet-352	215	4	fda	ORG
admet-352	216	1	nda 208542	ORG
admet-352	217	1	april 12, 2016	DATE
admet-352	218	1	23	CARDINAL
admet-352	219	1	lee	PERSON
admet-352	219	2	m.y. cha	PERSON
admet-352	219	3	m. kim	PERSON
admet-352	220	1	2014	DATE
admet-352	221	1	24	CARDINAL
admet-352	221	2	h. sakagami	PERSON
admet-352	221	3	s. konagai	PERSON
admet-352	221	4	h. yamamoto	PERSON
admet-352	223	1	74(19	CARDINAL
admet-352	223	2	2014	DATE
admet-352	223	3	1728	CARDINAL
admet-352	224	1	25	CARDINAL
admet-352	224	2	y. jia	PERSON
admet-352	224	3	j. juarez	PERSON
admet-352	224	4	m. manuia	PERSON
admet-352	224	5	g. lelais	PERSON
admet-352	225	1	74(19	CARDINAL
admet-352	225	2	2014	DATE
admet-352	225	3	1734	CARDINAL
admet-352	226	1	26	CARDINAL
admet-352	226	2	s. kasibhatla	PERSON
admet-352	226	3	j. li	PERSON
admet-352	226	4	c. tompkins	PERSON
admet-352	227	1	74(19	CARDINAL
admet-352	227	2	2014) 1733	DATE
admet-352	228	1	27	CARDINAL
admet-352	228	2	h. nokihara	PERSON
admet-352	228	3	h. murakami	PERSON
admet-352	228	4	asco meet	PERSON
admet-352	229	1	33(15_suppl	CARDINAL
admet-352	229	2	2015	CARDINAL
admet-352	230	1	28	CARDINAL
admet-352	230	2	g. lelais	PERSON
admet-352	230	3	r. epple	GPE
admet-352	231	1	michellys	PERSON
admet-352	232	1	2015	CARDINAL
admet-352	232	2	2585	CARDINAL
admet-352	233	1	29	CARDINAL
admet-352	235	1	30	CARDINAL
admet-352	235	2	a. ullrich	PERSON
admet-352	235	3	j. schlessinger	PERSON
admet-352	236	1	61(2	CARDINAL
admet-352	236	2	1990	DATE
admet-352	237	1	203–212	CARDINAL
admet-352	238	1	31	CARDINAL
admet-352	238	2	s. kono	PERSON
admet-352	238	3	a. flacco	PERSON
admet-352	238	4	clin	PERSON
admet-352	240	1	2010	DATE
admet-352	240	2	5581–5590	CARDINAL
admet-352	241	1	32	CARDINAL
admet-352	241	2	m. tran-dubé	PERSON
admet-352	241	3	h. shen	PERSON
admet-352	241	4	j. med	PERSON
admet-352	242	1	54(18	CARDINAL
admet-352	242	2	2011	DATE
admet-352	242	3	6342–6363	CARDINAL
admet-352	243	1	33	CARDINAL
admet-352	243	2	shaw	PERSON
admet-352	243	3	s.h. ou	PERSON
admet-352	243	4	y.j	GPE
admet-352	244	1	j. med	PERSON
admet-352	245	1	371(21	CARDINAL
admet-352	245	2	2014	DATE
admet-352	245	3	1963–1971	DATE
admet-352	246	1	34	CARDINAL
admet-352	246	2	solomon	PERSON
admet-352	246	3	t. mok	PERSON
admet-352	246	4	d.w.	PERSON
admet-352	247	1	kim	PERSON
admet-352	248	1	j. med	PERSON
admet-352	249	1	2014	DATE
admet-352	249	2	2167–2177	CARDINAL
admet-352	250	1	35	CARDINAL
admet-352	250	2	e. felip	PERSON
admet-352	250	3	s. orlov	PERSON
admet-352	250	4	k. park	PERSON
admet-352	251	1	j. clin	PERSON
admet-352	252	1	oncol.	DATE
admet-352	253	1	33	CARDINAL
admet-352	253	2	2015) 8060	DATE
admet-352	254	1	36	CARDINAL
admet-352	254	2	h. balke-want	PERSON
admet-352	254	3	f. malchers	PERSON
admet-352	254	4	clin	PERSON
admet-352	256	1	2012	DATE
admet-352	256	2	4682–4690	CARDINAL
admet-352	257	1	37	CARDINAL
admet-352	257	2	y.l. choi	PERSON
admet-352	257	3	m. soda	PERSON
admet-352	257	4	y. yamashita	ORG
admet-352	258	1	j. med	PERSON
admet-352	259	1	363(18	CARDINAL
admet-352	259	2	2010	DATE
admet-352	259	3	1734–1739	CARDINAL
admet-352	260	1	38	CARDINAL
admet-352	260	2	r. katayama	PERSON
admet-352	260	3	a.t. shaw	PERSON
admet-352	260	4	t.m.	PERSON
admet-352	260	5	khan et al	PERSON
admet-352	260	6	sci	ORG
admet-352	262	1	4(120	CARDINAL
admet-352	262	2	2012) 120ra17	DATE
admet-352	263	1	39	CARDINAL
admet-352	263	2	j. gainor	PERSON
admet-352	263	3	s.h. ou	PERSON
admet-352	263	4	j. logan	PERSON
admet-352	263	5	l.f. borges	PERSON
admet-352	263	6	a.t. sahw	PERSON
admet-352	264	1	j. thorac	PERSON
admet-352	266	1	8(12	CARDINAL
admet-352	266	2	2013	DATE
admet-352	266	3	1570–1573	DATE
admet-352	267	1	40	CARDINAL
admet-352	267	2	a.t. shaw	PERSON
admet-352	267	3	s.h. ou	PERSON
admet-352	268	1	j. clin	PERSON
admet-352	269	1	oncol	TIME
admet-352	270	1	2015) 1881–88	DATE
admet-352	271	1	41	CARDINAL
admet-352	271	2	r. doebele	PERSON
admet-352	271	3	d. aisner	ORG
admet-352	272	1	clin	PERSON
admet-352	274	1	18(5	CARDINAL
admet-352	274	2	2012	DATE
admet-352	275	1	1472–1482	DATE
admet-352	275	2	m. mendez et al	PERSON
admet-352	275	3	5(1	CARDINAL
admet-352	275	4	2017	CARDINAL
admet-352	275	5	1	CARDINAL
admet-352	275	6	42	CARDINAL
admet-352	275	7	l. friboulet	PERSON
admet-352	275	8	n. li	PERSON
admet-352	275	9	r. katayama	PERSON
admet-352	276	1	4(6	CARDINAL
admet-352	277	1	2014	DATE
admet-352	277	2	662–673	CARDINAL
admet-352	278	1	43	CARDINAL
admet-352	278	2	k. kinoshita	PERSON
admet-352	278	3	k. asoh	PERSON
admet-352	278	4	n. furuchi	PERSON
admet-352	278	5	al bioorg	PERSON
admet-352	279	1	med. chem	ORG
admet-352	280	1	20(3	CARDINAL
admet-352	280	2	2012	DATE
admet-352	280	3	1271–1280	DATE
admet-352	281	1	44	CARDINAL
admet-352	281	2	k. kiura	PERSON
admet-352	281	3	m. nishio	PERSON
admet-352	283	1	14(7	ORDINAL
admet-352	283	2	2013	DATE
admet-352	283	3	590	CARDINAL
admet-352	284	1	45	CARDINAL
admet-352	284	2	t. tamura	PERSON
admet-352	284	3	t. seto	PERSON
admet-352	284	4	k. nakagawa	PERSON
admet-352	284	5	radiat	GPE
admet-352	285	1	oncol.	DATE
admet-352	286	1	2014	DATE
admet-352	286	2	s6	GPE
admet-352	287	1	46	CARDINAL
admet-352	287	2	s. gadgeel	PERSON
admet-352	287	3	l. gandhi	PERSON
admet-352	287	4	g. riely	PERSON
admet-352	289	1	15	CARDINAL
admet-352	289	2	1119–1128	DATE
admet-352	290	1	47	CARDINAL
admet-352	290	2	j. wu	PERSON
admet-352	290	3	j. savooji	PERSON
admet-352	290	4	d. liu	PERSON
admet-352	291	1	j. hematol	PERSON
admet-352	292	1	oncol.	DATE
admet-352	293	1	9 (	PERCENT
admet-352	293	2	9	CARDINAL
admet-352	294	1	48	CARDINAL
admet-352	294	2	r. anjum	PERSON
admet-352	294	3	d. miller	PERSON
admet-352	294	4	73(8	CARDINAL
admet-352	294	5	2013	DATE
admet-352	294	6	5655	MONEY
admet-352	295	1	49	CARDINAL
admet-352	295	2	v. rivera	PERSON
admet-352	295	3	f. wang	PERSON
admet-352	295	4	r. anjum	PERSON
admet-352	296	1	72(8	CARDINAL
admet-352	296	2	2012	DATE
admet-352	296	3	1794	MONEY
admet-352	297	1	50	CARDINAL
admet-352	297	2	l. bazhenova	PERSON
admet-352	297	3	r. salgia	PERSON
admet-352	298	1	j. clin	PERSON
admet-352	299	1	oncol.	DATE
admet-352	300	1	33	CARDINAL
admet-352	301	1	51	CARDINAL
admet-352	301	2	a. vaishnavi	PERSON
admet-352	301	3	m. capelletti	PERSON
admet-352	301	4	a.t. le	ORG
admet-352	302	1	nat	PERSON
admet-352	304	1	19(11	CARDINAL
admet-352	304	2	2013	DATE
admet-352	304	3	1469–1472	DATE
admet-352	305	1	52	CARDINAL
admet-352	305	2	m. menichincheri	PERSON
admet-352	305	3	c. de ponti	PERSON
admet-352	306	1	8(12	CARDINAL
admet-352	306	2	2009	DATE
admet-352	307	1	53	CARDINAL
admet-352	307	2	m. patel	PERSON
admet-352	307	3	t. bauer	PERSON
admet-352	307	4	s. liu	PERSON
admet-352	308	1	j. clin	PERSON
admet-352	309	1	oncol.	DATE
admet-352	310	1	33	CARDINAL
admet-352	310	2	2596	DATE
admet-352	311	1	54	CARDINAL
admet-352	311	2	t. johnson	PERSON
admet-352	311	3	p. richardson	PERSON
admet-352	311	4	s. bailey	PERSON
admet-352	312	1	j. med	PERSON
admet-352	313	1	57(11	CARDINAL
admet-352	313	2	2014	DATE
admet-352	313	3	4720–4744	CARDINAL
admet-352	314	1	55	CARDINAL
admet-352	314	2	t. li	PERSON
admet-352	314	3	p. lorusso	PERSON
admet-352	314	4	m. maitland	PERSON
admet-352	315	1	j. hematol	PERSON
admet-352	316	1	oncol.	DATE
admet-352	317	1	9 (	PERCENT
admet-352	317	2	23	CARDINAL
admet-352	318	1	56	CARDINAL
admet-352	318	2	j. heuckmann	PERSON
admet-352	318	3	e. de stanchina	PERSON
admet-352	319	1	2011	DATE
admet-352	319	2	4920–4931	CARDINAL
admet-352	320	1	57	CARDINAL
admet-352	320	2	m. cheng	PERSON
admet-352	320	3	m. quail	PERSON
admet-352	320	4	d. girgrich	GPE
admet-352	321	1	11	CARDINAL
admet-352	321	2	2012	DATE
admet-352	322	1	670–679	CARDINAL
admet-352	323	1	58	CARDINAL
admet-352	323	2	i. sullivan	PERSON
admet-352	323	3	d.	NORP
admet-352	325	1	adv	PERSON
admet-352	325	2	med.	PERSON
admet-352	326	1	2016	CARDINAL
admet-352	326	2	32–47	CARDINAL
admet-352	327	1	59	CARDINAL
admet-352	327	2	s. gettinger	PERSON
admet-352	328	1	j. clin	PERSON
admet-352	330	1	2010	DATE
admet-352	330	2	4953–4960	DATE
admet-352	331	1	60	CARDINAL
admet-352	331	2	e. normant	PERSON
admet-352	331	3	g. paez	PERSON
admet-352	331	4	k. west	PERSON
admet-352	332	1	2011	DATE
admet-352	332	2	2581–2586	CARDINAL
admet-352	333	1	61	CARDINAL
admet-352	333	2	m. socinski	PERSON
admet-352	333	3	j. goldman	PERSON
admet-352	333	4	i. el-harary	PERSON
admet-352	334	1	clin	PERSON
admet-352	336	1	19(11	CARDINAL
admet-352	336	2	2013) 3068–3077	DATE
admet-352	337	1	2017	CARDINAL
admet-352	337	2	iapc	ORG
admet-352	337	3	zagreb	GPE
admet-352	337	4	croatia	GPE
admet-352	338	1	http://creativecommons.org/licenses/by/3.0/	ORG
admet-352	339	1	http://creativecommons.org/licenses/by/3.0/	ORG